Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDR | P35968 | 9/20 | 0.70 |
| ▸ | FLT1 | P17948 | 5/20 | 0.51 |
| ▸ | FLT4 | P35916 | 5/20 | 0.51 |
| ▸ | CNR2 | P34972 | 3/20 | 0.46 |
| ▸ | FLT3 | P36888 | 1/20 | 0.40 |
| ▸ | HTR6 | P50406 | 1/20 | 0.39 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.38 |
| ▸ | PDGFRB | P09619 | 2/20 | 0.35 |
| ▸ | PDGFRA | P16234 | 2/20 | 0.35 |
| ▸ | HTR1D | P28221 | 1/20 | 0.35 |
| ▸ | ALPL | P05186 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7549622 | 0.88 | KDR (0.55) | KDRFLT1FLT4CNR2FLT3 | |
| SCHEMBL7986796 | 0.86 | CNR2 (0.52) | KDRFLT1FLT4CNR2FLT3 | |
| SCHEMBL7554218 | 0.86 | KDR (0.71) | KDRFLT1FLT4CNR2 | |
| SCHEMBL7555811 | 0.85 | KDR (0.50) | KDRCNR2FLT3HTR6PDGFRB | |
| SCHEMBL7993934 | 0.85 | KDR (0.70) | KDRFLT1FLT4CNR2 | |
| SCHEMBL7994193 | 0.84 | KDR (0.49) | KDRFLT1FLT4CNR2FLT3 | |
| SCHEMBL7990474 | 0.84 | KDR (0.71) | KDRFLT1FLT4CNR2CYP2A6 | |
| SCHEMBL7990673 | 0.83 | KDR (0.69) | KDRFLT1FLT4CNR2FLT3 | |
| SCHEMBL7553991 | 0.83 | KDR (1.00) | KDRFLT1FLT4FLT3CYP2A6 | |
| SCHEMBL7987725 | 0.82 | KDR (0.70) | KDRFLT1FLT4CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6265403-B1 | TYROSINE INHIBITORS | MERCK & CO., INC. | 2001-07-24 | — | — | US | disclosed |